Shetye G - Search Results

1

Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB.

Chandrasekera NS, Berube BJ, Shetye G, Chettiar S, O'Malley T, Manning A, Flint L, Awasthi D, Ioerger TR, Sacchettini J, Masquelin T, Hipskind PA, Odingo J, Parish T. Chandrasekera NS, et al. Among authors: shetye g. ACS Infect Dis. 2017 Dec 8;3(12):898-916. doi: 10.1021/acsinfecdis.7b00112. Epub 2017 Oct 31. ACS Infect Dis. 2017. PMID: 29035551 Free PMC article.

2

Anti-Microbial Activity of Aliphatic Alcohols from Chinese Black Cardamom (Amomum tsao-ko) against Mycobacterium tuberculosis H37Rv.

Lee SY, Shetye GS, Son SR, Lee H, Klein LL, Yoshihara JK, Ma R, Franzblau SG, Cho S, Jang DS. Lee SY, et al. Among authors: shetye gs. Plants (Basel). 2022 Dec 21;12(1):34. doi: 10.3390/plants12010034. Plants (Basel). 2022. PMID: 36616162 Free PMC article.

3

Synthesis, antimycobacterial, cytotoxicity, anti-inflammatory, in silico studies and molecular dynamics of pyrazole-embedded thiazolidin-4-one hybrids.

Kamat V, Poojary B, Puthran D, Das VB, Kumar BK, Sankaranarayan M, Shetye G, Ma R, Franzblau SG, Nayak SP. Kamat V, et al. Among authors: shetye g. Arch Pharm (Weinheim). 2023 Mar;356(3):e2200444. doi: 10.1002/ardp.202200444. Epub 2022 Dec 2. Arch Pharm (Weinheim). 2023. PMID: 36461683

4

New Rufomycins from Streptomyces atratus MJM3502 Expand Anti-Mycobacterium tuberculosis Structure-Activity Relationships.

Zhou B, Shetye G, Wolf NM, Chen SN, Qader M, Ray GJ, Lankin DC, Cho S, Cheng J, Suh JW, Franzblau SG, McAlpine JB, Pauli GF. Zhou B, et al. Among authors: shetye g. Org Lett. 2022 Oct 14;24(40):7265-7270. doi: 10.1021/acs.orglett.2c02493. Epub 2022 Oct 4. Org Lett. 2022. PMID: 36194676 Free PMC article.

5

Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.

Nandikolla A, Srinivasarao S, Khetmalis YM, Kumar BK, Murugesan S, Shetye G, Ma R, Franzblau SG, Sekhar KVGC. Nandikolla A, et al. Among authors: shetye g. Toxicol In Vitro. 2021 Aug;74:105137. doi: 10.1016/j.tiv.2021.105137. Epub 2021 Mar 6. Toxicol In Vitro. 2021. PMID: 33684466

6

Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase.

Kim HB, Bacik JP, Wu R, Jha RK, Hebron M, Triandafillou C, McCown JE, Baek NI, Kim JH, Kim YJ, Goulding CW, Strauss CEM, Schmidt JG, Shetye GS, Ryoo S, Jo EK, Jeon YH, Hung LW, Terwilliger TC, Kim CY. Kim HB, et al. Among authors: shetye gs. PLoS One. 2022 Nov 17;17(11):e0277670. doi: 10.1371/journal.pone.0277670. eCollection 2022. PLoS One. 2022. PMID: 36395154 Free PMC article.

7

Discovery of a New Antibiotic Demethoxytetronasin Using a Dual-Sided Agar Plate Assay (DAPA).

Lee JH, Ma R, Nguyen L, Khan S, Qader M, Mpofu E, Shetye G, Krull NK, Augustinović M, Omarsdottir S, Cho S, Franzblau SG, Murphy BT. Lee JH, et al. Among authors: shetye g. ACS Infect Dis. 2023 Aug 11;9(8):1593-1601. doi: 10.1021/acsinfecdis.3c00171. Epub 2023 Jul 14. ACS Infect Dis. 2023. PMID: 37450563 Free article.

8

Antimycobacterial Rufomycin Analogues from Streptomyces atratus Strain MJM3502.

Zhou B, Shetye G, Yu Y, Santarsiero BD, Klein LL, Abad-Zapatero C, Wolf NM, Cheng J, Jin Y, Lee H, Suh JW, Lee H, Bisson J, McAlpine JB, Chen SN, Cho SH, Franzblau SG, Pauli GF. Zhou B, et al. Among authors: shetye g. J Nat Prod. 2020 Mar 27;83(3):657-667. doi: 10.1021/acs.jnatprod.9b01095. Epub 2020 Feb 7. J Nat Prod. 2020. PMID: 32031795 Free PMC article.

9

Syntheses and studies of deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with potent anti-tuberculosis activity and improved metabolic properties.

Liu R, Marshall K, Ma R, Lien Thi Pham K, Shetye G, Liu Z, Cho S, Jeong H, Franzblau SG, Moraski GC, Miller MJ. Liu R, et al. Among authors: shetye g. Bioorg Chem. 2022 Nov;128:106074. doi: 10.1016/j.bioorg.2022.106074. Epub 2022 Aug 12. Bioorg Chem. 2022. PMID: 35987188 Free PMC article.

10

One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.

Pasha MA, Mondal S, Panigrahi N, Shetye G, Ma R, Franzblau SG, Zheng YT, Murugesan S. Pasha MA, et al. Among authors: shetye g. Curr HIV Res. 2022;20(3):255-271. doi: 10.2174/1570162X20666220512163049. Curr HIV Res. 2022. PMID: 35549861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page